EyeGate Pharma Initiates Phase I Study of EGP-437 in Patients With Non-Necrotizing Anterior Scleritis WALTHAM, MA--(Marketwire - Feb 29, 2012) - EyeGate Pharma, a private specialty pharmaceutical company developing ocular therapeutics and a proprietary non-invasive drug delivery platform, announced...

EyeGate Pharma Initiates Phase III Study of EGP-437 in Patients With Anterior Uveitis WALTHAM, MA--(Marketwire - Jan 5, 2012) - EyeGate Pharma today announced that it has enrolled the first patient in a milestone Phase III pivotal study of its lead product EGP-437 (a late-stage...

Carling Communications, Inc. Hired as Agency of Record by ThromboGenics, Inc. SAN DIEGO, CA--(Marketwire - Apr 19, 2011) - San Diego based healthcare communications agency, Carling Communications, Inc. has been chosen by ThromboGenics, Inc. as its agency of record for its brand...

Compulink's Advantage/EHR(TM) Receives ONC-ATCB 2011/2012 Certification WESTLAKE VILLAGE, CA--(Marketwire - October 7, 2010) -  Compulink Business Systems, Inc., the industry leader in fully customizable electronic health records (EHR) and practice management...

Compulink Business Systems, Inc. Underwrites Grant for Joint Commission on Allied Health Personnel in Ophthalmology WESTLAKE VILLAGE, CA--(Marketwire - September 7, 2010) - Compulink Business Systems, Inc., the industry leader in fully customizable electronic health records (EHR) and practice management solutions,...